Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
309M
-
Number of holders
-
252
-
Total 13F shares, excl. options
-
317M
-
Shares change
-
+2.92M
-
Total reported value, excl. options
-
$3.74B
-
Value change
-
+$16.4M
-
Put/Call ratio
-
0.8
-
Number of buys
-
133
-
Number of sells
-
-90
-
Price
-
$11.78
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q1 2024
292 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock as of Q1 2024.
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) has 252 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 317M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (28.2M shares), PERCEPTIVE ADVISORS LLC (28.1M shares), Avoro Capital Advisors LLC (27.4M shares), BlackRock Inc. (22.8M shares), WELLINGTON MANAGEMENT GROUP LLP (18.8M shares), JPMORGAN CHASE & CO (15.7M shares), JANUS HENDERSON GROUP PLC (13.8M shares), Redmile Group, LLC (13.3M shares), STATE STREET CORP (12.4M shares), and WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (11.5M shares).
This table shows the top 252 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.